A randomized trial of pegylated recombinant human granulocyte-colony stimulating factor to prevent febrile neutropenia in breast cancer after chemotherapy
机构：[1]Hebei Med Univ, Hosp 4, Shijiazhuang, Peoples R China河北医科大学第四医院外一科临床科室[2]Baoding First Cent Hosp, Baoding, Peoples R China[3]Hebei Gen Hosp, Dept Glandular Surg, Shijiazhuang, Peoples R China[4]Shijiazhuang Peoples Hosp, Shijiazhuang, Peoples R China[5]Xingtai Peoples Hosp, Xingtai, Peoples R China
第一作者机构：[1]Hebei Med Univ, Hosp 4, Shijiazhuang, Peoples R China
推荐引用方式(GB/T 7714)：
Zhang Lina,Li Yuntao,Fan Zhonglin,et al.A randomized trial of pegylated recombinant human granulocyte-colony stimulating factor to prevent febrile neutropenia in breast cancer after chemotherapy[J].JOURNAL OF CLINICAL ONCOLOGY.2022,40(16):doi:10.1200/JCO.2022.40.16_suppl.e12516.
APA：
Zhang, Lina,Li, Yuntao,Fan, Zhonglin,Wang, Meiqi,Hui, Tianli...&Geng, Cuizhi.(2022).A randomized trial of pegylated recombinant human granulocyte-colony stimulating factor to prevent febrile neutropenia in breast cancer after chemotherapy.JOURNAL OF CLINICAL ONCOLOGY,40,(16)
MLA：
Zhang, Lina,et al."A randomized trial of pegylated recombinant human granulocyte-colony stimulating factor to prevent febrile neutropenia in breast cancer after chemotherapy".JOURNAL OF CLINICAL ONCOLOGY 40..16(2022)
医学